Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDPsychemedics Cor Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
Psychemedics Cor Earnings Date And Information
Psychemedics Cor last posted its earnings results on Tuesday, February 10th, 2015. The company reported $0.13 earnings per share for the quarter, topping analysts' consensus estimates of $0.08 by $0.05. The company had revenue of 4.43 M for the quarter and had revenue of 19.69 M for the year. Psychemedics Cor has generated $0 earnings per share over the last year ($-0.32 diluted earnings per share) and currently has a price-to-earnings ratio of -45.48. Psychemedics Cor has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Psychemedics Cor Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/24/2025 | Q4 2024 | N/A | $0.03 | N/A | N/A | $4.43 M |
| 11/12/2024 | Q3 2024 | N/A | -$0.09 | N/A | $5.18 M | $5.18 M |
| 08/13/2024 | Q2 2024 | N/A | -$0.14 | N/A | $4.73 M | $4.73 M |
| 05/14/2024 | Q1 2024 | N/A | -$0.12 | N/A | $8.17 M | $5.36 M |
| 03/28/2024 | Q4 2023 | N/A | -$0.16 | N/A | $5.89 M | $5.00 M |
| 11/13/2023 | Q3 2023 | N/A | -$0.36 | N/A | $4.21 M | $5.70 M |
| 08/14/2023 | Q2 2023 | N/A | -$0.13 | N/A | $787.46 K | $5.54 M |
| 05/11/2023 | Q1 2023 | N/A | -$0.07 | N/A | $8.74 M | $5.86 M |
| 03/27/2023 | Q4 2022 | N/A | -$0.12 | N/A | $6.30 M | $5.70 M |
| 11/10/2022 | Q3 2022 | N/A | -$0.02 | N/A | N/A | $6.52 M |
| 08/10/2022 | Q2 2022 | N/A | -$0.06 | N/A | N/A | $6.51 M |
| 05/11/2022 | Q1 2022 | N/A | $0.01 | N/A | $9.35 M | $6.51 M |
| 03/30/2022 | Q4 2021 | N/A | -$0.29 | N/A | N/A | $6.44 M |
| 11/15/2021 | Q3 2021 | N/A | $0.13 | N/A | N/A | $6.67 M |
| 08/12/2021 | Q2 2021 | N/A | $0.02 | N/A | N/A | $6.09 M |
| 05/13/2021 | Q1 2021 | N/A | $0.01 | N/A | $10.00 M | $5.71 M |
| 03/26/2021 | Q4 2020 | N/A | -$0.10 | N/A | N/A | $5.34 M |
| 11/10/2020 | Q3 2020 | N/A | -$0.20 | N/A | N/A | $5.17 M |
| 08/13/2020 | Q2 2020 | N/A | -$0.37 | N/A | N/A | $3.31 M |
| 05/15/2020 | Q1 2020 | N/A | -$0.03 | N/A | $9.09 M | $7.54 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Psychemedics Cor Earnings: FAQ's
In the previous quarter, Psychemedics Cor (:PMD) reported $0.13 earnings per share (EPS) to beat the analysts' consensus estimate of $0.08 by $0.05.
The conference call for Psychemedics Cor's latest earnings report can be listened to online.
The conference call transcript for Psychemedics Cor's latest earnings report can be read online.
Psychemedics Cor (:PMD) has a recorded annual revenue of $19.69 M.
Psychemedics Cor (:PMD) has a recorded net income of $-1,861,000.Psychemedics Cor has generated $-0.32 earnings per share over the last four quarters.
Psychemedics Cor (:PMD) has a price-to-earnings ratio of -45.48 and price/earnings-to-growth ratio is -1.22.